Asthma and COVID-19: What do we know now

被引：19
|
作者：
Hughes-Visentin, Alexzandra [1 ]
Paul, Anthea B. Mahesan [2 ]
机构：
[1] Univ Ottawa, Fac Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2020年 / 14卷
关键词：
COVID-19; asthma; respiratory; biologics; treatment; corticosteroids; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; PNEUMONIA; SARS-COV-2; NEBULIZER; WUHAN; RISK;
D O I：
10.1177/1179548420966242
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
引用
收藏
页数：7
相关论文
共 50 条
  • [41] What do we know about Kawasaki disease and COVID-19?
    Alberto Hernandez Arias, Jeffrey James William
    Herrera de la Hoz, Rosa Elena
    Lequerica Segrera, Pedro Luis
    ANDES PEDIATRICA, 2021, 92 (02): : 281 - 287
  • [42] COVID-19 and Anemia: What Do We Know So Far?
    Abu-Ismail, Luai
    Taha, Mohammad J. J.
    Abuawwad, Mohammad T.
    Al-Bustanji, Yaqeen
    Al-Shami, Khayry
    Nashwan, Abdulqadir
    Yassin, Mohamed
    HEMOGLOBIN, 2023, 47 (03) : 122 - 129
  • [43] Facing the COVID-19 outbreak: What should we know and what could we do?
    Yang, Yi
    Shang, Weilong
    Rao, Xiancai
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) : 536 - 537
  • [44] What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (01): : 27 - 33
  • [45] Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?
    Musa, Sherief
    ARAB JOURNAL OF GASTROENTEROLOGY, 2020, 21 (01) : 3 - 8
  • [46] COVID-19 and Cardiovascular Surgery. Do We Know What We Are Dealing With?
    Almeida, Rui M. S.
    Marin-Cuartas, Mateo
    Garcia-Villarreal, Ovidio A.
    Dayan, Victor
    BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, 2021, 36 (06) : III - IV
  • [47] Awareness of the Egyptian public about COVID-19: what we do and do not know
    Sabry, Nirmeen
    ElHadidi, Seif
    Kamel, Ahmed
    Abbassi, Maggie
    Farid, Samar
    INFORMATICS FOR HEALTH & SOCIAL CARE, 2021, 46 (03): : 244 - 255
  • [48] Long COVID: what do we know now and what are the challenges ahead?
    Pereira, Snehal M. Pinto
    Newlands, Fiona
    Anders, Jake
    Banerjee, Amitava
    Blandford, Ann
    Brown, Kate
    Beale, Sarah
    Bu, Feifei
    Fong, Wing Lam Erica
    Gilpin, Gina
    Hardelid, Pia
    Kovar, Jana
    Lim, Jason
    Park, Chloe
    Raveendran, Vishnuga
    Shah, Anoop D.
    Shao, Xin
    Wong, Andrew
    Stephenson, Terence
    Shafran, Roz
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2024, 117 (07) : 224 - 228
  • [49] COVID-19: What we can know
    Wildner, Manfred
    GESUNDHEITSWESEN, 2020, 82 (06) : 493 - 496
  • [50] Psychological Intervention and COVID-19: What We Know So Far and What We Can Do
    Inchausti, Felix
    MacBeth, Angus
    Hasson-Ohayon, Ilanit
    Dimaggio, Giancarlo
    JOURNAL OF CONTEMPORARY PSYCHOTHERAPY, 2020, 50 (04) : 243 - 250
12345